Unleashing nature's potential and limitations: Exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis (Review)
- PMID: 37680650
- PMCID: PMC10481116
- DOI: 10.3892/mi.2023.102
Unleashing nature's potential and limitations: Exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis (Review)
Abstract
Driven by the limitations and obstacles of the available approaches and medications for multiple sclerosis (MS) that still cannot treat the disease, but only aid in accelerating the recovery from its attacks, the use of naturally occurring molecules as a potentially safe and effective treatment for MS is being explored in model organisms. MS is a devastating disease involving the brain and spinal cord, and its symptoms vary widely. Multiple molecular pathways are involved in the pathogenesis of the disease. The present review showcases the recent advancements in harnessing nature's resources to combat MS. By deciphering the molecular pathways involved in the pathogenesis of the disease, a wealth of potential therapeutic agents is uncovered that may revolutionize the treatment of MS. Thus, a new hope can be envisioned in the future, aiming at paving the way toward identifying novel safe alternatives to improve the lives of patients with MS.
Keywords: antioxidants; molecular pathways; multiple sclerosis; naturally occurring molecules; neurodegenerative diseases; therapeutic approaches.
Copyright: © Fathallah et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Exploring Multiple Sclerosis (MS) and Amyotrophic Lateral Scler osis (ALS) as Neurodegenerative Diseases and their Treatments: A Review Study.Curr Top Med Chem. 2020;20(26):2391-2403. doi: 10.2174/1568026620666200924114827. Curr Top Med Chem. 2020. PMID: 32972341 Review.
-
Multiple Sclerosis: Therapeutic Strategies on the Horizon.Cureus. 2022 May 10;14(5):e24895. doi: 10.7759/cureus.24895. eCollection 2022 May. Cureus. 2022. PMID: 35706718 Free PMC article. Review.
-
Unveiling Nature's potential: Promising natural compounds in Parkinson's disease management.Parkinsonism Relat Disord. 2023 Oct;115:105799. doi: 10.1016/j.parkreldis.2023.105799. Epub 2023 Aug 10. Parkinsonism Relat Disord. 2023. PMID: 37633805 Review.
-
Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters.Int J Mol Sci. 2012;13(9):11783-11803. doi: 10.3390/ijms130911783. Epub 2012 Sep 18. Int J Mol Sci. 2012. PMID: 23109883 Free PMC article.
-
Multiple Sclerosis Pathogenesis and Updates in Targeted Therapeutic Approaches.Curr Allergy Asthma Rep. 2023 Sep;23(9):481-496. doi: 10.1007/s11882-023-01102-0. Epub 2023 Jul 4. Curr Allergy Asthma Rep. 2023. PMID: 37402064 Review.
References
Publication types
LinkOut - more resources
Full Text Sources